Covid-19 | CMC Vellore to conduct mixed-vaccine trial
The Hindu
DCGI nod is significant given shortage of Covaxin.
The Drug Controller General of India (DCGI) has approved a clinical trial, to be conducted by the Christian Medical College, Vellore, to evaluate if a mixed vaccine combination can work as opposed to the current policy of both doses being the same vaccine. India has administered 45.6 crore vaccine doses so far of which nearly 88% are Covishield. With limited supplies of Covaxin, a mixed dose regime may help cover a supply shortfall. “After detailed deliberation, the committee recommended for grant of permission for conduct of the Phase IV clinical trial,” said the minutes of the meeting that were made public on Friday, though details of the trial were not.More Related News

The Karnataka government on Friday handed over 10 cases related to two incidents that had turned into political flashpoints — the Hubballi woman “disrobing” case and the Ballari firing case in which a Congress worker was killed — to the Criminal Investigation Department (CID), a well-placed police source told The Hindu.












